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Abstract: The current investigation presents the synthesis, computational molecular-docking and biological activity studies of arylated
thiazole coumarins. Aryl substituted thiazolyl coumarin derivatives were synthesized via Suzuki cross-coupling reaction. A detailed
reaction condition optimization revealed that the Pd-PEPPSI-IPent precatalyst in only 2 mol% loading resulted in the desired product
with high yield. The aim of this study was to examine the antimicrobial behavior of thiazole coumarin derivatives through in vitro and in
silico studies. All the compounds showed activity against both antibacterial strains, Staphylococcus aureus and Escherichia coli, except
5d. Similarly, the compounds 5a, 5b, and 5d were found to be active against Trichoderma harzianum. The compound 5d of this series
was found to have a higher activity with MIC 125 mg/ml against Trichoderma harzianum. Molecular studies showed the high activities
of these compounds are due to the presence of strong H-bonding and π-π interaction with their respective targets. A good correlation
was observed between computational and in vitro studies.
Key words: Coumarin thiazole, Suzuki cross-coupling, molecular dynamics simulation, antibacterial activity, antifungal activity,
binding free energy calculation

1. Introduction
Antibiotic resistance is one of the leading public health concerns of the current age [1, 2], mainly due to the emergence,
spread, and persistence of multidrug-resistant (MDR) bacteria or ‘superbugs’ which cannot be treated with conventional
remedies. The plausible causes of the antimicrobial resistance are the widespread use of antibiotics and the weary antibiotic
research progress [3]. Similarly, the incidence of systemic fungal infection has become an important complication
and a major cause of morbidity and mortality in immune compromised individuals, such as those who are receiving
anticancer chemotherapy, those who have had organ transplants, and AIDS patients [4,5]. In many antimicrobial drugs,
the heterocyclic thiazole nucleus are an integral part of the drug as pharmacophore [6,7]. Drug designing techniques have
led to the designing of novel coumarin scaffold with various bioactive entities in order to realize pharmacophores with
good pharmacology as well as enhanced pharmacokinetics [8–10]. A large number of studies have been conducted on the
combined effect of thiazole and coumarin scaffolds that show improved biological activities [11–14]. The present study is
based on in vitro antibacterial and antifungal screening of small drug-like thiazole coumarin derivatives.
The advent of computational tools offers a rapid and complementary role in understanding the binding and inhibition
patterns of different drug-like molecules against a variety of targets [15,16]. Particularly, molecular docking analysis
helps to show the binding ability of ligands with desired targets [17–20]. The inhibitory potential of thiazole coumarin
derivatives has been explored herein using molecular docking to explain their inhibition activities against both bacterial
and fungal strains.
The basic core structure having thiazole and coumarin subunits has been synthesized through Knoevenagel
condensation [21], Pechmann reaction [22], and Hantzsch reaction [23], using readily available starting materials. Suzuki
cross-coupling reaction of organoboron compounds and organic halides is one of the most efficient methods for the
construction of carbon-carbon bonds [24]. Overall, the commercial availability and bench top stability of the starting
materials, mild reaction conditions, and the tolerance of a broad range of functionalities have extended the scope of the
* Correspondence: ahassan@qau.edu.pk
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reaction. The NHC bound family of palladium precatalysts, including Pd-PEPPSI-IMes, Pd-PEPPSI-IPr, and Pd PEPPSIIPent, serve as complementary; and in most cases, superior catalyst system has been widely utilized for a variety of cross
coupling reactions [25,26]. Herein, we report the computational docking and biological studies of the thiazolyl coumarin
derivatives synthesized through a facile Suzuki reaction.
2. Materials and methods
2.1. Chemical synthesis of the compounds
2.1.1. General experimental conditions
Chemicals were purchased from Merck KGaA (Darmstadt, Germay) and Sigma-Aldrich Corp. (St. Louis, MO, USA). IR
spectra were recorded on Schimadzu Fourier transform infrared spectrophotometer model 270 (Shimadzu Corporation,
Kyoto, Japan), using ATR (attenuated total reflectance) facility. All the reactions were monitored by Thin-layer
chromatography (TLC) using the precoated silica gel-60 F254 purchased from Merck KGaA. Flash column chromatography
was carried out with silica gel as stationary phase (particle size 200–300 mesh). High resolution mass spectrometric (HRMS)
experiments were carried out on Finnigan MAT-311A (Finnigan MAT GmbH, Bremen, Germany) mass spectrometer with
(ESI) ionization techniques. NMR spectra were obtained using a Bruker Avance 300 MHz spectrometer (Bruker BioSpin
Corp., Billerica, MA, USA) in deuterated chloroform using TMS as internal reference, at 300 MHz (1H NMR) and 75 MHz
(13C NMR). Chemical shifts are mentioned in delta (δ) units while coupling constants (J) values are in Hertz unit (Hz).
2.1.2. Synthesis of 6-bromo-3-(2-methylthiazol-4-yl)-2H-chromen-2-one (4)
The compound 4 was synthesized in slightly modified method already reported in the literature [27]. The overall synthesis
consists of the following 3 steps:
In a 250 mL 2-neck round bottom flask, 5-bromosalicyladehyde (2 g, 9.95 mmol), ethyl acetoacetate (1.9 mL, 14.85
mmol), and piperidine (9 μL, 1.00 mmol) were added along with ethanol as solvent and the mixture was heated at 50 °C
for 8 h. Water (20 mL) was added to quench the reaction, and the organic layer was separated. The aqueous layer was
extracted with ethyl acetate (20 mL × 3). The combined organic layer was dried using sodium sulphate and concentrated
under vacuum. The product 2 was obtained as yellow solid (2.18 g) in 82% yield.
3-Acetyl-6-bromo-2H-chromen-2-one 2 (1.5 g, 5.62 mmol) in dichloromethane (28 mL, 0.2 M) was added to the
mixture in the 2-neck round bottom flask in an ice bath. Bromine (0.15 mL, 5.62 mmol) was added dropwise, and the
reaction was allowed to cool to ambient temperature overnight. Water (25 mL) was added to quench the reaction and
extracted with dichloromethane (30 mL × 3). The combined organic layer was concentrated in vacuo to obtain compound
3 as yellow solid (1.63 g) in 84% yield.
A 2-neck round bottom flask was filled with 6-bromo-3-(2-bromoacetyl)-2H-chromen-2-one 3 (1 g, 2.89 mmol) and
thioacetamide (326.0 mg, 4.34 mmol) in ethanol (15 mL, 0.2 M). The reaction mixture was heated at 60 °C for 16 h, and
the progress of the reaction was monitored by TLC. After the completion of the reaction, the solvent was evaporated in
vacuo, and the crude product was purified by flash chromatography (n-hexane: ethyl acetate 20:1). The compound 4 was
obtained as yellow solid in 80% yield (745 mg).
Physical data of 4:

Rf = 0.5 (n-Hex: EtOAc, 9:1)
1
HNMR (300 MHz, CDCl3, δ ppm): 8.61 (s, 1H, H2), 8.31 (s, 1H, H1), 7.72 (d, 1H, J = 2.4 Hz, H3), 7.63 (d, 1H, J = 8.7
Hz, H4), 7.24 (d, 1H, J = 8.6 Hz, H5), 2.77 (s, 3H, CH3)
13
CNMR (75 MHz, CDCl3, δ ppm): 165.1, 158.6, 151.8, 146.9, 137.7, 134.2, 130.5, 122.0, 121.1, 120.4, 119.2, 118.1, 18.3.
HRMS-ESI (m/z): Calcd. for C13H9BrNO2S, [M+H] +:321.9532, found 321.9537.
FTIR (neat): ῡ (cm–1) = 3076, 1693 (C=O), 1632, 1593, 1489, 1370, 1182, 1091, 961.
2.1.3. General procedure for Suzuki coupling
An oven dried 100 × 13 mm sealed tube having magnetic bead was charged with thaizole-coumarin substrate (4, 100
mg, 0.31 mmol), boronic acid (0.46 mmol), KOtBu (70 mg, 0.62 mmol) and Pd-PEPPSI-IPent precatalyst (4.8 mg, 0.006
mmol) in toluene (1.5 mL, 0.2 M). The reaction was purged with nitrogen to develop an inert atmosphere. The reaction
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was carried out at 80 °C for 24 h. The reaction mixture was allowed to cool at room temperature and loaded onto silica gel,
purified via flash column chromatography (SiO2, using solvent system of n-Hexane and ethyl acetate in ratio of 9:1), and
afforded the desired products 5a–5e in good to excellent yields.
2.1.4. Characterization data of 5a–5e:
3-(2-methylthiazol-4-yl)-6-phenyl-2H-chromen-2-one (5a)
The reaction was set up with phenylboronic acid (56 mg, 0.46 mmol). The product 5a was obtained as white solid in 90%
yield (89 mg).
M.P. 192–194 oC, Rf = 0.52, (n-Hex: EtOAc, 9:1)

HNMR(300 MHz, CDCl3, δ ppm): 8.67 (s, 1H, H2), 8.34 (s, 1H, thiazole H1), 7.83 (d, 1H, J = 2.1 Hz, H3), 7.78 (dd, 1H,
J = 8.7, 2.1 Hz, H4), 7.63 (d, 1H, J = 8.7 Hz, H5) 7.39–7.53 (m, 5H, phenyl), 2.80 (s, 3H, thiazole-CH3).
13
C NMR (75 MHz, CDCl3, δ ppm): 165.8, 159.8, 151.8, 146.9, 139.5, 137.8, 134.2, 130.5, 129.1, 127.8, 127.1, 121.9,
121.1, 120.4, 118.1, 117.2, 19.2.
HRMS-ESI (m/z): Calcd. for C19H14NO2S, [M+H]+: 320.0740, found 320.0746.
FTIR (neat): ῡ (cm–1) = 3086, 1688(C=O), 1650, 1541, 1452, 1365, 1133, 1092, 963.
3-(2-methylthiazol-4-yl)-6-o-tolyl-2H-chromen-2-one (5b)
The reaction was set up with o-tolylboronic acid (63 mg, 0.46 mmol). The product 5b was obtained as white solid in
94% yield (97 mg).
1

M.P. 192–195 oC, Rf = 0.53, (n-Hex: EtOAc, 9:1)
1
HNMR (300 MHz, CDCl3, δ ppm): 8.76 (s, 1H, H2), 8.35 (s, 1H, thiazole H1), 7.58 (d, 1H, J = 1.8 Hz, H3), 7.52 (dd,
1H, J = 1.8, 8.7 Hz, H4), 7.43 (d, 1H, J = 8.7 Hz, H5), 7.24–7.33 (m, 4H-phenyl), 2.80 (s, 3H, thiazole-CH3), 2.31 (s, 3H,
phenyl-CH3).
13
C NMR (75 MHz, CDCl3, δ ppm): 165.5, 159.8, 152.0, 147.5, 140.1, 139.2, 138.5, 135.4, 132.6, 130.6, 129.8, 128.6,
127.9, 126.1, 121.2, 119.8, 119.2, 116.1, 20.5, 19.2.
HRMS-ESI (m/z): Calcd. for C20H16NO2S, [M+H]+: 334.0896, found 334.0898.
FTIR (neat): ῡ (cm–1) = 3081, 1681 (C=O), 1649, 1553, 1457, 1368, 1165, 1088, 954.
3-(2-methylthiazol-4-yl)-6-m-tolyl-2H-chromen-2-one (5c)
The reaction was set up with m-tolylboronic acid (63 mg, 0.46 mmol). The product 5c was obtained as white solid in
85% yield (88 mg).

M.P. 196–197 °C, Rf = 0.53, (n-Hex: EtOAc, 9:1)
1
HNMR (300 MHz, CDCl3, δ ppm): 8.84 (s, 1H, H2), 8.35 (s, 1H, thiazole H1), 7.81 (d, 1H, J = 2.1 Hz, H3), 7.77 (dd,
1H, J = 2.4, 8.4 Hz, H4), 7.23(d, 1H, J = 8.4 Hz, H5), 7.22–7.45 (m, 4H, H-phenyl), 2.82 (s, 3H, thiazole-CH3), 2.46 (s, 3H,
phenyl-CH3).
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C NMR(75 MHz, CDCl3, δ ppm): 165.4, 159.7, 152.5, 150.0, 145.4, 139.3, 138.3, 136.5, 132.8, 130.3, 129.9, 128.4,
127.8, 127.4, 126.4, 122.3, 121.6, 116.3, 22.3, 19.4.
HRMS-ESI (m/z): Calcd. for C20H16NO2S, [M+H]+: 334.0896, found 334.0899.
FTIR (neat): ῡ (cm–1) = 3087, 1691 (C=O), 1646, 1578, 1489, 1371, 1172, 1091, 958.
6-(4-methoxyphenyl)-3-(2-methylthiazol-4-yl)-2H-chromen-2-one (5d)
The reaction was set up with p-methoxyphenylboronic acid (70 mg, 0.46 mmol). The product 5d was obtained as white
solid in 94% yield (99 mg).
13

M.P. 194–198 oC, Rf = 0.51, (n-Hex: EtOAc, 9:1)
1
H NMR (300 MHz, CDCl3, δ ppm): 8.82 (s, 1H, H2), 8.35 (s, 1H, thiazole H1), 7.77 (d, 1H, J = 2.1 Hz, H3), 7.74 (dd,
1H, J = 2.1, 8.7 Hz, H4), 7.56 (d, 2H, J = 8.7 Hz, phenyl H-2,6), 7.43 (d, 1H, J = 8.4 Hz, H5), 7.03 (d, 2H, J = 8.7 Hz, phenyl
H-3,5), 3.89 (s, 3H, methoxy), 2.82 (s, 3H, thiazole-CH3).
13
C NMR (75 MHz, CDCl3, δ ppm): 164.3, 158.5, 149.7, 146.5, 139.1, 136.7, 134.1, 129.8, 128.9, 127.1, 126.8, 120.8,
120.1, 119.5, 119.1, 58.7, 19.3.
HRMS-ESI (m/z): Calcd. for C20H16NO3S [M+H]+: 350.0845, found 350.0847.
FTIR (neat): ῡ (cm–1) = 3084, 1686 (C=O), 1642, 1573, 1484, 1372, 1178, 1096, 951.
3-(2-methylthiazol-4-yl)-6-(naphthalen-1-yl)-2H-chromen-2-one (5e)
The reaction was set up with 1-naphthylboronic acid (79 mg, 0.46 mmol). The product 5e was obtained as white solid
in 88% yield (101 mg).

M.P. 199–194 oC, Rf = 0.53, (n-Hex: EtOAc, 9:1)
1
HNMR (300 MHz, CDCl3, δ ppm): 8.79 (s, 1H, H2), 8.37 (s, 1H, thiazole H1), 7.75 (d, 1H, J = 1.5 Hz, H3), 7.68 (dd, 1H,
J = 1.8, 8.4 Hz, H4), 7.97–7.45 (m, 8H), 2.80 (s, 3H, thiazole-CH3).
13
C NMR (75 MHz, CDCl3, δ ppm): 165.5, 159.9, 152.3, 147.4, 139.3, 138.3, 137.4, 133.8, 133.4, 129.4, 128.5, 128.3,
127.2, 126.5, 126.1, 125.5, 125.4, 121.3, 119.8, 116.3, 19.2.
HRMS-ESI (m/z): Calcd. for C23H16NO2S [M+H]+: 370.0896, found 370.0900.
FTIR (neat): ῡ (cm–1) = 3091, 1679 (C=O), 1644, 1579, 1493, 1365, 1191, 1078, 939.
2.2. Biological activities of the compounds
2.2.1. Antibacterial assay
A strain of gram-positive bacteria Staphylococcus aureus (ATCC: 6538) and gram-negative bacteria Escherichia coli
(ATCC: 8739) were obtained from the culture collections of SA-Centre for Interdisciplinary Research in Basic Science (SACIRBS), IIUI. Both cultures were refreshed in nutrient broth. The bacterial culture was grown in nutrient agar to obtain
single colonies of both strains. After culturing and refreshing, antibacterial activity was performed via agar well diffusion
method. The media was prepared by suspending 2.8 gm of nutrient agar powder in 100 mL of distilled water in a flask.
The media was autoclaved at 121 °C for 15 min; afterwards, it was left to cool but not solidify. About 20 mL of the media
was poured into each petri dish in a laminar flow hood. The petri dishes were left on the sterile surface until the media
solidified. Lids were placed on each petri dish. Bacterial dilution in saline solution was prepared according to McFarland
standard. The agar plate surface was inoculated by pouring 100 µL of bacterial suspension over the entire agar surface and
spreading it with glass rod [28]. The plates were left for drying. A 6 to 8 mm-diameter hole was punched aseptically with
a sterile cork borer, and 20 µL of each compound was introduced into the well. DMSO (dimethyl sulfoxide) and PenStrep
were used as negative and positive control. The agar plates were incubated at 25 °C for 24 h. The antimicrobial agent
diffused in the agar medium and inhibited the growth of microbes. In initial step, qualitative test was performed to find
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out active compounds, followed by minimum inhibitory concentration (MIC) was performed on the active compounds.
The concentration for MIC includes 500, 250, 125, 62.5, and 31.25 µg/mL[29].
2.2.2. Antifungal assay
The fungal strain Trichoderma harzianum was obtained from culture collections of SA-Centre for Interdisciplinary
Research in Basic Science (SA CIRBS), IIUI. Single spore technique was used for Trichoderma harzianum to get a pure
culture. The culture was refreshed in potato dextrose agar (PDA). Antifungal activity was performed via agar well diffusion
method. The PDA plate surface was inoculated by pouring 100 µL of fungal suspension over the entire agar surface and
spreading it with a glass rod. The fungal suspension was prepared by mixing fungal spores in autoclaved distilled water.
The plates were left to dry. Then, a hole with a diameter of 6 to 8 mm was punched aseptically with a sterile cork borer, and
20 µL of each compound was introduced into the well. DMSO and fluconazole were used as positive and negative control.
The agar plates were incubated at 25 °C for 4 days. Similar to the antibacterial assay, a qualitative test was also performed
in antifungal activity to find out active compounds, and then minimum inhibitory concentration (MIC) was carried out
on active compounds against Trichoderma harzianum to find out the lowest concentration of compound that inhibits the
growth of fungus. Serial dilution of compounds was performed. The concentration for MIC includes 500, 250, 125, 62.5,
and 31.25 µg/mL.
2.2.3. Molecular docking studies
The 3D structures of antibacterial target (PDB id 1YLJ) [30] and antifungal target (PDB id 2YOK) were fetched from Protein
Data Bank1, and all the atoms were prepared, charged, protonated, and minimized via MOE 2016 suite. The chemical
structures of the synthesized compounds were built and saved in their 3D conformations by Builder tool incorporated in
MOE 2016. The following factors were used for energy minimization gradient: 0.05, Force Field: MMFF94X+Solvation,
Chiral Constraint: Current Geometry. Energy minimization was terminated when the root mean square gradient fell below
0.005. The minimized structures of the complexes were used as the template for molecular docking. Ten conformations
were generated for each docked ligand-target complex. Lowest energy minimized conformation of each docked complex
was used for further analysis.
3. Results and discussion
3.1. Chemical synthesis
The thiazole-coumarin substrate was prepared in 3 steps following a slightly modified reported procedure[14]. In the first
step, a Knoevenagel condensation using 5-bromosalicylaldehyde and ethyl acetoacetate was performed in the presence
of catalytic amount of piperidine to obtain 3-acetyl-6-bromo-2H-chromen-2-one (2) in 80% isolated yield. In the second
step, the intermediate was further treated with bromine in dichloromethane to obtain the monobromination product 3 in
82% yield. Finally, the Hantzch thiazole synthesis of 3 with thioacetamide formed the thiazole coumarin product 4 having
bromo substituent at 6-position in 85% isolated yield (Scheme 1).
Suzuki coupling is one of the most efficient and widely used methods for the C-C coupling, yet there are some
shortcomings associated with the reaction. The scramble product formation, and catalyst decomposition may occur during
the course of reaction. In addition, the associated homo coupled by-product can diminish the desire product and may
hamper the isolation of the pure product. To mitigate these problems, an exhaustive reaction condition optimization maybe
required to get the coupled product in good yield. The screening of reaction conditions was performed, and the results are
given in Table 1. Initially, the coupling of thiazolyl substituted 6-bromocoumarin (4) and phenylboronic acid in the presence

Scheme 1. The synthesis of thiazole coumarin derivative 4.
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Table 1. Reaction condition optimization for Suzuki coupling of thiazole coumarin
derivative and the structure of the catalyst and liganda.
S. No.

Pd Catalyst

Ligand

Base

Solvent

Yield%

1.

Pd(OAc)2

PPh3

K2CO3

Toluene

22

2.

Pd(OAc)2

PPh3

K2CO3

THF

22

3.

Pd(OAc)2

JohnPhos

K2CO3

Toluene

38

4.

PdCl2dppf

-

K2CO3

Toluene

35

5.

Pd-PEPPSI-IPr

-

K2CO3

Toluene

25

6.

Pd-PEPPSI-IPr

-

t

KO Bu

Toluene

46

7.

Pd-PEPPSI-IPent

-

t

KO Bu

Toluene

95

8.

Pd-PEPPSI-IPent

-

NaOtBu

Toluene

32

9.

Pd-PEPPSI-IPent

-

b

KO Bu

Toluene

33

10.

c

Pd-PEPPSI-IPent

-

KOtBu

Toluene

90

t

Reaction conditions: thiazole coumarin (4, 0.31 mmol, 100 mol%), boronic acid (0.46
mmol, 150 mol%), base (0.62 mmol, 200 mol %,), Pd-catalyst (0.016 mmol, 5 mol%),
ligand (0.037 mmol, 12 mol%), toluene (0.2 M), 80 °C, 24 h. bKOtBu (0.93 mmol, 300
mol%), cPd-PEPPSI-IPent (0.006 mmol, 2 mol%) was used.
a

of palladium acetate, triphenylphosphine, and potassium carbonate in toluene as a solvent provided the desired product 5a
in only 22% isolated yield (entry 1). During the solvent screening, change of solvent from toluene to THF could not improve
the yield (entry 2). The study of the ligands revealed that utilizing JohnPhos as the ligand resulted in a moderately improved
38% yield, while pre-formed PdCl2dppf catalyst provided a similar yield (entries 3-4). The sterically demanding Buchwald
ligands can withstand the test of time for variety of coupling reactions [31], and the bidentate ferrocene based DPPF ligand
favors the reductive elimination during the catalytic cycle. Both of the above ligands have shown some improvement in the
coupling reaction. The strong sigma donor N-heterocyclic carbene (NHC) based Pd-PEPPSI family of precatalyst systems
have been developed by Prof. Michael G. Organ, and these have shown eclectic utility and robustness [32]. Therefore,
employing precatalyst Pd-PEPPSI-IPr under otherwise similar conditions resulted in 25% desired product (entry 5). When
the reaction was performed by switching the base to KtOBu, the desired 5a was formed with enhanced yield (entry 6). To
our delight, when the reaction was performed with more sterically demanding Pd-PEPPSI-IPent catalyst in the presence of
KtOBu in toluene, the product 5a was obtained in 95% yield (entry 7). At this point, when the reaction was further tested
with NatOBu or with higher loading of KtOBu, the yield could not be improved (entries 8-9). Lowering the Pd-PEPPSIIPent catalyst loading upto 2 mol%, the yield of the desired product was 90% (entry 10). Thus increasing or decreasing the
base loading or changing the type of base could not improve the yield. As previous studies of PEPPSI precatalyst explored
the importance of sterics in the backbone of the NHC core in the cross coupling reactions, which prompted us to prompted
to optimize the steric bulk of NHC core of the Pd-PEPPSI precatalyst. The optimizations (Table 1) showed that a moderate
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yield of the final coupled product was obtained with Pd-PEPPSI-IPr, while a quantitative yield was obtained when PdPEPPSI-IPent was used. Thus, the suitable catalyst for the current Suzuki cross coupling of thiazolyl coumarin system was
found to be Pd-PEPPSI-IPent.
Various types of boronic acids were utilized to extend the scope of reaction. Structurally variable arylated thiazole
coumarins were synthesized as per optimized reaction conditions, as shown in Table 2. Alkyl, alkoxy, and aryl-substituted
boronic acids were employed in the reaction, leading to the formation of the final arylated product in excellent yields.
o-tolylboronic acid was reacted under the optimized conditions, yielding the desired product 5b in 94% isolated yield,
while m-tolylboronic acids resulted in the final coupled product 5c in 85% yield. Similarly, 4-methoxypenylboronic acid
resulted in the end product 5d in 91% yield. 1-Naphthylboronic acid also provided the comparable yield of 88% of the
desired product 5e.
3.2. Biological evaluation of the compounds
3.2.1. Antibacterial assay
Qualitative test was performed to screen active compounds against a strain of gram-positive bacteria Staphylococcus
aureus (ATCC: 6538) and a strain of gram-negative bacteria Escherichia coli (ATCC: 8739).
All the compounds showed activity against both strains except 5d. PenStrep and DMSO were used as positive control
and negative control respectively. Compound 5a showed higher inhibition against both gram-positive and gram-negative
bacteria (Table 3).
The minimum inhibitory concentration (MIC) of 5a, 5b, 5c, and 5e was determined by agar well diffusion method.
The concentration of the compounds ranges from 31.25 to 500 µg/mL. The MIC value of 5a was determined to be 62.5
µg/mL against both gram-positive and gram-negative bacteria. The compound 5b exhibited MIC at 500 µg/mL against
Staphylococcus aureus and 125 µg/mL against Escherichia coli (Tables 4 and 5).
Table 2. Derivatization of thiazolyl coumarin substrate with different boronic acids.

Table 3. Zone of inhibition of thiazole coumarin derivatives against 2
strains of bacteria.

S. No.

1616

Zone of inhibition (mm)
Compounds

Staphylococcus aureus

Escherichia coli

1

5a

15

17

2

5b

13

16

3

5c

15

13

4

5d

-

-

5

5e

11

11
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3.2.2. Antifungal assay
The synthesized compounds were also tested on strain of Trichoderma harzianum on PDA plates. Concentration of the
compounds used was 1 mg/mL in DMSO. Three out of 5 compounds showed inhibition of Trichoderma harzianum.
Miltefosine and DMSO were used as positive control and negative control respectively. Compound 5d was found to be
more active against Trichoderma harzianum (Table 6).
The MIC of synthesized compounds was determined by agar well diffusion method. Compounds 5a, 5b, and 5d were
tested for their MIC value. Only compound 5d showed MIC value at concentration 125 µg/mL against Trichoderma
harzianum (Table 7).
Table 4. Minimum inhibitory concentration of active compounds against Staphylococcus
aureus (+).
Concentrations (µg/mL)
S. No.

Compounds

500

250

125

62.5

31.25

7
-

-

Zone of inhibitions (mm)
5a
5b
5c
5e

1
2
3
4

13
10
12
8

11
9
-

10
-

Table 5. Minimum inhibitory concentration of active compounds against Escherichia coli
(–).
Concentrations (µg/mL)
S. No.

Compounds

500

250

125

62.5

31.25

9
-

-

Zone of inhibitions (mm)
5a
5b
5c
5e

1
2
3
4

15
14
8
9

12
13
-

10
10
-

Table 6. Zone of inhibition of thiazole coumarin derivatives
against Trichoderma harzianum.
S. No.

Compounds

1
2
3
4
5
6

5a
5b
5c
5d
5e
Miltefosine

Zone of inhibition (mm)
Trichoderma harzianum.
11
13
14
17

Table 7. MIC of active compound against Trichoderma harzianum.

S. No.

Compounds

1

5d

Concentrations (µg/mL)
500
250
125
Zone of inhibitions (mm)
13
11
9

62.5

31.25

-

-

1617
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Figure 1. 3D & 2D docked poses of compounds of the target 1YLJ. a) 5a docked in the active site, b) 5a among the key amino
acid residues of the protein, c) 5b docked in the active site, d) 5b among the key amino acid residues of the protein, e) 5d
docked in the active site, f) 5d among the key amino acid residues of the protein.

1618

PARVEEN et al. / Turk J Chem
3.2.3. Docking study of bacterial protein
Bacterial protein PDB ID 1YLJ was downloaded from Protein Data Bank and prepared in molecular operating environment
(MOE) for docking. Ligand was removed, and mdb file of compounds were docked in place of ligand. The results are
mentioned in Table 8. As stated in antibacterial activity section, compounds 5a and 5b were found to be the most active
derivatives against Staphylococcus aureus (ATCC: 6538) and gram-negative bacteria Escherichia coli (ATCC: 8739).
The main purpose of docking studies was to investigate the possible interaction of these compounds with target. Active
site of target 1YLJ based on hydrophobic and hydrophilic amino acids, such as Asp131, Tyr105, Ser130, Thr235, Tyr129,
Leu127, Lys234, Ala126, Thr216, Gln128, Asp233, Ala218, Thr215, Gly217, Asn214, Gly217, Thr215, Ser237, Ser70, Lys73,
Ser130, and Arg276. All docked compounds showed strong hydrogen binding with Thr216, Asn214, Lys234, Thr216,
Ser130, Lys73, Ser70, and Ser237, in addition to arene-π interactions with Lys234 and Arg276, as shown in Figure 1. High
antibacterial behavior of compounds 5a and 5b may be due to their strong hydrophobic and hydrophilic interactions
with key amino acids, as shown in Table 8. Aromatic moiety of compound 5a has arene-π interactions with Lys234, and
N-atom showed hydrogen bonding with Thr216 at distance of 1.82 Å. All the thiazole coumarins compounds bind at the
same place.
3.2.4. Antifungal docking results
The results showed that the thiazole coumarin derivatives have some antifungal activity. According to antifungal screening,
3 of the synthesized compounds effectively inhibited the growth of the tested fungal strain. Compound 5d showed the
best activity in inhibiting the growth of the fungal strain. In order to check the inhibition pattern of tested compound,
molecular docking of compounds against target PDB id: 2YOK was performed. The high inhibitory activity of compound
5d may be attributed to its strong binding interactions with Thr259, Arg280, Arg264, and Arg407. Methoxy group at para
position of ring and the carbonyl of compound showed H-binding with Arg260 and Thr259 with distances of 2.63 & 2.5 Å,
respectively. Similarly, aromatic moieties of compound 5b showed arene-π interactions with Arg407-Arg264. Compound
5c and 5e did not show any type of interactions with key residues, as shown in Table 9. Activity of compounds 5a, 5b, and
5d is due to their strong hydrophobic and hydrophilic interactions with key residues, as shown in Figure 2.
Table 8. Hydrophobic and hydrophilic interactions of docked compounds in active site of 1YLJ.
H-bonding

π-π interaction

Distance (Å)

Amino acids

Amino acids

Binding energy
(KJ/mol)

5a

1.82

Thr216

Lys234

–10.12

17

2.

5b

2.15, 3.19 2.27

Ser130, Lys73 Ser70

-

–10.34

16

3.

5c

2.56

Ser70

Arg276

–10.91

13

4.

5d

-

-

-

–10.34

-

5.

5e

2.11

Thr216

Lys234

-–10.65

11

6.

Penicillin

2.19, 2.63

Ser130, Ser70

Arg276

–11.32

28

Sr. No.

Compounds

1.

ZI (mm)
Escherichia coli

Table 9. Dock binding interactions of antifungal drugs with PDB id: 2YOK.
H-bonding

π-π interact.

ZI (mm)
Trichoderma
harzianum

Distance (Å)

Amino acids

Amino Acids

Binding energy
(KJ/mol)

5a

2.73

Arg280

Arg264

–10.42

11

2.

5b

2.46

Arg407

Arg280, Arg264

–10.39

13

3.

5c

-

-

-

–10.87

-

4.

5d

2.5, 2.63

Thr259, Arg280

Arg264, Arg407

–11.34

14

5.

5e

-

-

-

–10.67

-

6.

Miltefosine

2.65,2.12
2.15,3.11

Gly A256, Arg A280,
Arg A350, Pro A103

-

–11.37

17

Sr. No.

Compounds

1.
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Figure 2. 3D & 2D docked view of thiazole coumarins in active site of fungal target. Dotted lines showed the binding interactions with
key amino acids. a) 5a docked in the active site, b) 5a among the key amino acid residues of the protein, c) 5b docked in the active site,
d) 5b among the key amino acid residues of the protein, e) 5d docked in the active site, f) 5d among the key amino acid residues of the
protein.
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4. Conclusion
Pd-PEPPSI-catalyzed Suzuki coupling strategy was utilized to cross couple thiazole-coumarin based coumarin derivatives
with array of substituted aryl boronic acid to synthesize arylated thiazole coumarins in excellent yield using mild reaction
conditions. Molecular docking studies were performed to evaluate the drug-like potential of the synthesized moieties.
These studies were performed to investigate the interaction modes between the compounds and active site of antibacterial
and antifungal drug targets. A good correlation was observed between in vitro and in silico studies. It can be inferred that
the synthesized thiazole coumarin derivatives are useful to assess in further studies to develop new antimicrobial agents
with higher efficacy.
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